baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

GlycoMimetics Inc/ US38000Q1022 /

5/21/2024 10:00:00 PM	Chg. -0.0135	Volume	Bid1:23:11 PM	Ask1:23:11 PM	High	Low
0.2754USD	-4.67%	1.2 mill. Turnover: 299,992.3851	0.2736Bid Size: 7,200	0.2800Ask Size: 4,100	0.2900	0.2754

GlobeNewswire 3/28 Apollomics Highlights Clinical Progress and Reports Full Year 2023 Financial Results

GlobeNewswire 1/9 Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030

GlobeNewswire 1/3 Apollomics Completes Enrollment in Phase 3 Bridging Study of Uproleselan in Chinese Patients with Re...

GlobeNewswire 10/25/2023 Korro Bio Announces Appointment of Tim Pearson to Board of Directors Upon Closing of the Proposed Me...

GlobeNewswire 9/28/2023 Apollomics Reports First Half 2023 Financial Results and Provides Corporate Update

GlobeNewswire 11/22/2021 Apollomics Inc. Doses First Patient in Phase 3 Clinical Trial with APL-106 (Uproleselan Injection) i...

GlobeNewswire 6/28/2021 POINT Biopharma Strengthens Senior Management Team with Appointment of Dr. Myra Rosario Herrle as EV...

GlobeNewswire 3/19/2021 BioCryst Appoints Helen Thackray, M.D., as Chief Research and Development Officer

GlobeNewswire 3/4/2021 Apollomics, Inc. Announces Successful Enrollment of First Patient Into Phase 1 Clinical Trial of APL...

GlobeNewswire 1/7/2021 APL-106 (uproleselan) Granted Breakthrough Therapy Designation in China for the Treatment of Acute M...

GlobeNewswire 12/12/2020 Annual Changes to the Nasdaq Biotechnology Index

GlobeNewswire 9/28/2020 Apollomics, Inc. Receives China Investigational New Drug Approval for APL-106 to Initiate a Phase 3 ...

GlobeNewswire 4/16/2020 Spero Announces Appointment of Scott Jackson to its Board of Directors

GlobeNewswire 9/23/2019 BioCryst Appoints Helen Thackray, M.D., to Board of Directors

GlobeNewswire 4/11/2019 Factors of Influence in 2019, Key Indicators and Opportunity within Monster Beverage, Kennametal, Wa...

GlobeNewswire 2/11/2019 Detailed Research: Economic Perspectives on Waddell & Reed Financial, Kennametal, Automatic Data Pro...

GlobeNewswire 8/31/2018 Research Report Identifies FS Investment, Rush Enterprises, GlycoMimetics, Federal Signal, ATN Inter...

GlobeNewswire 7/27/2018 Factors of Influence in 2018, Key Indicators and Opportunity within Minerals Technologies, USG, Cont...

GlobeNewswire 7/3/2018 Cancer Therapies: World Industry Analysis & Forecasts to 2030 - Key Company Profiles, Emerging Techn...

GlobeNewswire 5/22/2018 New Research Coverage Highlights Apollo Commercial Real Estate Finance, Drive Shack, GlycoMimetics, ...

GlobeNewswire 3/29/2018 New Research Coverage Highlights Healthcare Trust of America, Drive Shack, Chemed, AMERISAFE, Medica...

GlobeNewswire 2/7/2018 Cancer Stem Cell Therapies Market, 2030

GlobeNewswire 1/26/2018 New Research: Key Drivers of Growth for NanoString Technologies, Oaktree Capital Group, Midstates Pe...

GlobeNewswire 12/9/2017 Annual Changes to the NASDAQ Biotechnology Index

GlobeNewswire 6/13/2017 LifeSci Advisors' Board Placement Initiative Announces Eighth Board Placement

GlycoMimetics Inc/ US38000Q1022 /

If you wish to receive reply to your feedback, please provide your email address.